Item Details

Print View

Cost-Benefit, Cost-Effectiveness Research of Drug Abuse Prevention: Implications for Programming and Policy

editors, William J. Bukoski, Richard I. Evans
Format
Book
Published
Rockville, MD : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research, 1998.
Language
English
Series
NIDA Research Monograph
NIH Publication
Contents
  • Impact of substance abuse on federal spending
  • Historical perspective on effective prevention
  • School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness
  • Effectiveness of prevention interventions with youth at high risk of drug abuse
  • Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention
  • Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention
  • Analytic issues for estimating the benefits and costs of substance abuse prevention
  • Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings
  • Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth
  • Implications for prevention policy: a commentary.
Description
iv, 233 p. : ill. ; 24 cm.
Notes
  • "Based on the papers from a technical review ... held on July 28-29, 1994."--p. ii.
  • Includes bibliographical references.
Series Statement
NIDA research monograph ; 176
NIH publication no. 98-4021
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 02612nam a2200385Ia 4500
    001 u3653004
    003 SIRSI
    005 19980909112551.0
    008 980825s1998 mdua b 000 0 eng d
    035
      
      
    a| (Sirsi) u80756
    035
      
      
    a| (OCoLC)40216284
    040
      
      
    a| MMU c| MMU d| VAM
    049
      
      
    a| VAMO
    245
    0
    0
    a| Cost-benefit, cost-effectiveness research of drug abuse prevention : b| implications for programming and policy / c| editors, William J. Bukoski, Richard I. Evans.
    260
      
      
    a| Rockville, MD : b| U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research, c| 1998.
    300
      
      
    a| iv, 233 p. : b| ill. ; c| 24 cm.
    440
      
    0
    a| NIDA research monograph ; v| 176
    440
      
    0
    a| NIH publication v| no. 98-4021
    500
      
      
    a| "Based on the papers from a technical review ... held on July 28-29, 1994."--p. ii.
    504
      
      
    a| Includes bibliographical references.
    505
    0
      
    a| Impact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of drug abuse -- Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention -- Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention -- Analytic issues for estimating the benefits and costs of substance abuse prevention -- Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings -- Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth -- Implications for prevention policy: a commentary.
    596
      
      
    a| 19
    650
    1
    2
    a| Substance-Related Disorders x| prevention & control z| United States.
    650
    2
    2
    a| Substance-Related Disorders x| economics z| United States.
    650
    2
    2
    a| Cost-Benefit Analysis.
    700
    1
      
    a| Bukoski, William J.
    700
    1
      
    a| Evans, Richard I. q| (Richard Isadore), d| 1922-2015
    096
      
      
    a| WM 270 .C837 1998
    710
    2
      
    a| National Institute on Drug Abuse. b| Division of Epidemiology and Prevention Research.
    710
    2
      
    a| National Institutes of Health (U.S.)
    999
      
      
    a| SHELVED BY FIRST SERIES IN JRNLSTACKS w| HS-ASIS i| 3653004-1001 l| HS-CABELJR m| HEALTHSCI t| JRNL2WK
▾See more
▴See less

Availability

Google Preview

Google Books Preview
Library Location Map Availability Call Number
Health Sciences Cabell N/A Available Non-Circ.